Ottawa – The Patented Medicine Prices Review Board (PMPRB) published the 8th edition of its annual Meds Entry Watch report today. The analysis finds that the number of new medicines launched in Canada is higher than the median for Organisation for Economic Co-operation and Development (OECD) countries., Most new medicines come to market with high treatment costs, and specialty medicines such as biologic, …